1. New Products

New Products

Cat. No. Product Name Target Research Area Added Chemical Structure
HY-131340 LASSBio-1632

Phosphodiesterase (PDE)

Inflammation/Immunology

2020-08 LASSBio-1632
HY-131345 PI3Kα-IN-4

PI3K

Cancer

2020-08 PI3Kα-IN-4
HY-131337 RhlR antagonist 1

Bacterial

Infection

2020-08 RhlR antagonist 1
HY-136650 Fludarabine triphosphate

Nucleoside Antimetabolite/Analog; Drug Metabolite; DNA/RNA Synthesis; Apoptosis

Cancer

2020-08 Fludarabine triphosphate
HY-131342 BIIB068

Btk

Inflammation/Immunology

2020-08 BIIB068
HY-131336 MGS0274

mGluR

Neurological Disease

2020-08 MGS0274
HY-131339 SP-146

Aurora Kinase

Cancer

2020-08 SP-146
HY-131347 PD-1/PD-L1-IN-NP19

PD-1/PD-L1

Cancer;

Inflammation/Immunology

2020-08 PD-1/PD-L1-IN-NP19
HY-131343 HBV-IN-4

HBV; DNA/RNA Synthesis

Infection

2020-08 HBV-IN-4
HY-131335 p38α inhibitor 2

p38 MAPK

Inflammation/Immunology

2020-08 p38α inhibitor 2
HY-131349 CCR4 antagonist 3

CCR

Cancer

2020-08 CCR4 antagonist 3
HY-131346 HIF-PHD-IN-1

HIF/HIF Prolyl-Hydroxylase

Cardiovascular Disease

2020-08 HIF-PHD-IN-1
HY-131338 RORγt inverse agonist 13

ROR

Inflammation/Immunology

2020-08 RORγt inverse agonist 13
HY-P1257A Xenin-8 TFA

Others

Metabolic Disease

2020-08 Xenin-8 TFA
HY-P1290A PKA Inhibitor Fragment (6-22) amide TFA

PKA

Neurological Disease

2020-08 PKA Inhibitor Fragment (6-22) amide TFA
HY-121899 1-Oxo Ibuprofen

Others

Others

2020-08 1-Oxo Ibuprofen
HY-131030 JF669, SE

Others

Others

2020-08 JF669, SE
HY-14604 Xaliproden hydrochloride

5-HT Receptor; Dopamine Receptor

Neurological Disease

2020-08 Xaliproden hydrochloride
HY-13567 Bendamustine

DNA Alkylator/Crosslinker; Apoptosis

Cancer

2020-08 Bendamustine
HY-100663 Gefitinib impurity 2

Others

Others

2020-08 Gefitinib impurity 2